Secondary Prevention for Atherosclerotic Cardiovascular Disease

Secondary Prevention for Atherosclerotic Cardiovascular Disease

Faculty and Program

Recent Trial Data and Guideline Recommendations, Drs. Doll and Latif
Addressing Gaps in ASCVD Care: SCAI Secondary Prevention Toolkit, Drs. Mukherjee and Paul
Panel Discussion: Variations in Practice

	Jacob A. Doll, MD, FSCAI VA Puget Sound Health Care System		Shea Elizabeth Hogan, MD, FSCAI Denver Health Medical Center
	Faisal Latif, MD, FSCAI The University of Oklahoma Health Sciences Center		Debabrata Mukherjee, MD, FSCAI Texas Tech University Health Sciences Center El Paso
	Timir K. Paul, MD, PhD, FSCAI The University of Tennessee Health Science Center

Acknowledgement of Commercial Support

This activity is supported by a sponsorship from Amgen.

Learning Objectives

Upon completion of these activities, participants will be able to:

Identify gaps in CVD risk assessment, counseling, and guideline-directed medical therapy
Discuss how interventionalists can help address these gaps
Utilize SCAI toolkit and shared decision-making tools

Accredited Continuing Education Information

This activity is not certified for accredited continuing education.

Summary


Cost:	FREE


Credit Offered:	0.75 Participation Credit